Uniondale, NYNCT06679829Now EnrollingIRB Ready

Multiple Myeloma Clinical Trial in Uniondale, NY

Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Uniondale. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this Uniondale location

Preparing your pre-screening questions...

Expert Care in Uniondale

Access multiple myeloma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple myeloma treatment provided free

Apply for This Uniondale Location

Check if you qualify for this multiple myeloma clinical trial in Uniondale, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Uniondale

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Uniondale site if eligible
  4. 4Begin participation

About This Multiple Myeloma Study in Uniondale

The purpose of this study is to see if siltuximab plus population pharmacokinetic (PK)-dosed melphalan works as well as the usual approach (body surface area \[BSA\]-dosed melphalan) in people with multiple myeloma (MM) who are receiving an autologous stem cell transplant (ASCT) as part of their standard treatment. The researchers will also see if siltuximab in combination with population PK-dosed melphalan works to decrease symptoms after an ASCT, and will study the safety of siltuximab. For t

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Histologically-confirmed symptomatic multiple myeloma undergoing autologous HCT with plan off study for melphalan 140 or 200 mg/m2 undergoing HCT within 12 months of diagnosis.
At least 60 years of age
Have at least 3 million x 10\^6 CD34+ cells/kg to be infused
KPS performance status \>60% or ECOG Performance Status score of 0-2 Within 6 weeks prior to enrollment:
Diffusion capacity \>45% (adjusted for hemoglobin) as predicted by pulmonary function testing.
LVEF \>45% by MUGA or rest ECHO
Clinical laboratory values meeting the following criteria
Platelet count ≥ 20 x 10\^9/L
ALT and AST ≤ 2.5 x ULN o Total bilirubin ≤ 2.5 x ULN; except if the elevation is due to Gilbert's syndrome
Calculated creatinine clearance \> 40 mL/min
Before enrollment, all women are expected to be not of childbearing potential as they will be age 60+.
A man who is sexually active with a woman of childbearing potential and has not had a vasectomy must agree

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Uniondale?

Yes, this clinical trial (NCT06679829) has an active research site in Uniondale, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Myeloma Treatment Options in Uniondale, NY

If you're searching for multiple myeloma treatment options in Uniondale, NY, this clinical trial (NCT06679829) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Uniondale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple myeloma clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Uniondale, NY

See all multiple myeloma clinical trials recruiting in Uniondale — not just this study.

Browse Multiple Myeloma Trials in Uniondale

Browse More Trials by Condition

Ready to Join in Uniondale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Uniondale, NY